Lipoprotein subfractions and cardiovascular disease risk

  title={Lipoprotein subfractions and cardiovascular disease risk},
  author={Ronald M. Krauss},
  journal={Current Opinion in Lipidology},
  • R. Krauss
  • Published 1 August 2010
  • Biology
  • Current Opinion in Lipidology
Purpose of review Subfractions of LDL and HDL defined by differences in particle size and density have been associated to varying degrees with risk of cardiovascular disease (CVD). Assessment of these relationships has been clouded by lack of standardization among the various analytic methodologies as well as the strong correlations of the subfractions with each other and with standard lipid and lipoprotein risk markers. This review summarizes the properties of the major LDL and HDL particle… 
Classification of LDL Phenotypes by 4 Methods of Determining Lipoprotein Particle Size
Substantial agreement is found in the reported LDL phenotype among 4 LDL subfraction measurement technologies as performed by different clinical reference laboratories.
Small Dense Low-Density Lipoprotein as Biomarker for Atherosclerotic Diseases
The development of homogeneous assays facilitated the LDL subfraction analysis making possible large clinical studies evaluating the significance of SDLDL in the development of cardiovascular disease, and guidelines are needed to establish guidelines for sdLDL evaluation and correction in clinical practice.
Lipoprotein Subfractions in Metabolic Syndrome and Obesity: Clinical Significance and Therapeutic Approaches
The clinical significance of sdLDL in being overweight and obesity, as well as the efficacy of anti-obesity drugs on LDL subfractions in these individuals are reviewed; a short comment on HDL subclasses is also included.
LDL particle number and size and cardiovascular risk: anything new under the sun?
An up-to-date perspective on the potential use of LDL particle number and size as complementary risk factors to predict and manage cardiovascular disease (CVD) risk in the clinical realm is provided.
Association of lipoprotein subclasses and carotid intima-media thickness in the Chinese population
Small dense LDL was a stronger predictor for carotid atherosclerosis in the general Chinese population when compared with HDL-C or HDL subclasses, which is independent of lipids and other related metabolic risks.
[ApoE-containing HDL and the development of atherosclerosis].
The results of epidemiological studies are inconclusive; some of them have demonstrated that high HDL- -apoE concentration has been associated with lower risk of developing coronary heart disease (CHD), while other studies have shown that high levels of HDL-apoE has been an independent risk factor for cardiovascular events and positively correlated with other risk factors for CHD.
Cholesteryl ester transfer protein, low density lipoprotein particle size and intima media thickness in patients with coronary heart disease.
CETP might play a role in determining lipoprotein distributions, but did not seem to be the sole factor in the formation of small LDL particles, and age, diastolic blood pressure, CETP concentration and LDL particle size were independent factors for determing IMT by multiple linear regression analysis.
Lipoprotein profile, lipoprotein-associated phospholipase A2 and cardiovascular risk in hemodialysis patients
Low-density lipoproteins show a more atherogenic phenotype than in the general population and Lp-PLA2 could potentially be used to evaluate cardiovascular risk in dialyzed patients.


Ion Mobility Analysis of Lipoprotein Subfractions Identifies Three Independent Axes of Cardiovascular Risk
Testing whether combinations of lipoprotein subfractions independently predict CVD in a prospective cohort of 4594 initially healthy men and women found three independent components of CVD risk, genetic analyses suggest these components represent independent mechanistic pathways for development ofCVD.
Systematic Review: Association of Low-Density Lipoprotein Subfractions With Cardiovascular Outcomes
A systematic review of the association between LDL subfractions and incidence and progression of clinical cardiovascular disease and focuses primarily on the LDL subFraction tests that are available for routine use by clinical laboratories and are thus available to all U.S. clinicians and their patients.
The predictive role of atherogenic dyslipidemia in subjects with non-coronary atherosclerosis.
  • K. Berneis, M. Rizzo, G. Rini
  • Medicine, Biology
    Clinica chimica acta; international journal of clinical chemistry
  • 2009
High-density lipoprotein subfractions and risk of coronary artery disease
Clinical trials show that raising total HDL cholesterol improves clinical and angiographic outcomes, but it remains to be determined whether a shift in distribution of HDL particles provides greater benefit than just an increase in total HDL.
High density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients.
There were strong inverse correlations between the plasma HDL2b concentration and both severity of lesions and rate of lesion progression in the normotriglyceridemic patients, whereas this relation was absent in subjects with hypertriglyceridemia.
Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.
The proposed genetic locus responsible for LDL subclass phenotypes also results in an atherogenic lipoprotein phenotype, found to be closely associated with variations in plasma levels of other lipid, lipop protein, and apolipoprotein measurements.
Metabolic origins and clinical significance of LDL heterogeneity DOI 10.1194/jlr.R200004-JLR200
Future delineation of the determinants of heterogeneity of LDL and other apoB-containing lipoproteins may contribute to improved identification and management of patients at high risk for atherosclerotic disease.